AzTrials
AzTrials

HealthyNCT07020234

National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics

A study testing Epigenetics Video and Nanotechnology Video in people with Healthy, run by Washington University School of Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Epigenetics Video and Nanotechnology Video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,040 participants
Where
1 siteUnited States
Study dates
12 Jun 2025to 18 Jul 2025
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • English language speaker,
  • Identify as one of five racial/ethnic groups:
  • Non-Hispanic White
  • Non-Hispanic Black,
  • Non-Hispanic Asian
  • Non-Hispanic Indigenous (i.e., Alaska Native/Native Hawaiians/American Indian/Other Pacific Islander)
  • Hispanic (all races)

Who cannot join

  • Self-identify as a genetics expert

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Washington University School of Medicine

    St Louis, Missouri, 63110

Other trials in United States

About this study

Official title: Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research: National Survey

Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that are understandable and that increase acceptance of using epigenetics in clinical settings.

Conditions
Healthy
Being tested
Epigenetics Video, Nanotechnology Video
Keywords
Epigenomics, Epigenetics, Genetics, Behavioral, Bioethics
Medical subject headings
Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Epigenetics VideoBehavioural

    Educational video about health and epigenetics.

  • Nanotechnology VideoBehavioural

    Educational video about nanotechnology

Study groups in NCT07020234
Study groupRoleWhat they receive
Epigenetics VideoExperimentalParticipants will watch a brief (<5 minute) video about the concept of Epigenetics
Receives: Behavioral: Epigenetics Video
Nanotechnology VideoActive comparatorParticipants will watch a brief (<5 minute) video about nanotechnology
Receives: Behavioral: Nanotechnology Video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge & Understanding of Epigenetics Information

    We will measure this outcome using a sum score of correct answers for 8 individual items. Scale ranges from 0 points to 8 points with higher scores indicating higher epigenetics knowledge.

    Measured: After intervention video

Secondary outcomes (2)
  1. Acceptability of Epigenetics Information

    We will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (items 1-7, ranging from 1 to 5 with higher scores indicating higher perceived benefits), perceived drawbacks of epigenetic research (items 8-10, ranging from 1 to 5 with higher scores indicating higher perceived drawbacks), and acceptance of using epigenetic research in medical support (items 11-13, ranging from 1 to 5 with higher scores indicating higher acceptance of using epigenetic research in medical support). Each item was analyzed separately.

    Measured: After intervention video

  2. Perceptions of Epigenetic Information

    We will measure this outcome using an 6 item scale. Scores range from 1 to 5, with higher scores indicating greater perceptions of epigenetic information.

    Measured: After intervention video

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2025
  2. Study start12 Jun 2025
  3. Primary completion18 Jul 2025
  4. Study completion18 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,040 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07020234
Sponsor's protocol ID
202503082
Other IDs
R01ES033743
Status last verified
Oct 2026
First submitted
5 Jun 2025
Last updated
14 Oct 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in